amfAR, The Foundation for AIDS Research
amfAR’s public policy office in Washington, D.C., educates policy makers, the media, and the public about evidence-based policies to address HIV/AIDS in the U.S. and around the world.
amfAR report spells out recommendations for health plans and health care purchasers
amfAR infographic illustrates the advances on global HIV/AIDS made possible by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).
The broad benefits of increased investment in HIV/AIDS research
New database enables users to access and understand PEPFAR programs and priorities at a deeper level than was previously possible.
amfAR’s issue briefs and short films make a convincing case for ending the ban on federal funding for syringe services programs.
Assessment of the
Use of Key Populations
Data in Domestic
Budgeting Practices in
Kenya and South Africa
An amfAR research team recently evaluated the extent to which PEPFAR funds were allocated to programs targeting populations at highest risk.
The number of Americans (3.2 million) living with chronic Hepatitis C Virus (HCV) is nearly five times the population of Washington, DC
Syringe services programs (SSPs) are proven to be a highly effective—and cost-effective—method of infectious disease prevention.
© 2016 amfAR All Rights Reserved